Tag: Sickle-Cell Anemia
Trial of Gene Therapy for Sickle Cell Disease Halted
Two patients participating in the study developed cancer years after treatment
ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD
Total hemoglobin, fetal Hb increased in seven patients with transfusion-dependent ß-thalassemia, three with sickle cell disease
ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD
Total hemoglobin, fetal Hb increased in five patients with transfusion-dependent ß-thalassemia, two with sickle cell disease
Medical Marijuana Tied to Fewer Admissions in Sickle Cell Disease
But no change in opioid use observed for those receiving medical marijuana certification
Endurance Exercise May Offer Vascular Benefit in Sickle Cell Disease
Increases in capillary density, functional exchange surface seen in microvasculature of skeletal muscle
Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease
Study seeks to recruit up to 45 adults with severe sickle cell disease
Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease
Fewer individuals in voxelotor group versus placebo group have worsened anemia at week 24
Increasing Dose for Total Body Irradiation Cuts Graft Failure
Findings seen in patients with severe hemoglobinopathies receiving haploidentical bone marrow transplantation
New Law Boosts Fight Against Sickle Cell Disease
In 2018, the National Institutes of Health was funded approximately $115 million for research of the disease
L-Glutamine Reduces Number of Pain Crises in Sickle Cell Disease
Significantly fewer pain crises, hospitalizations compared with those receiving placebo
